Krystal Biotech: Peers

The FY2024 (Dec) proxy of Krystal Biotech names 19 peer companies for pay. Among Krystal Biotech and these peers, CEO pay was 2nd highest of 9 and total shareholder return was 2nd highest of 9.

2nd highest of 9in Krystal Biotech and its pay peers, FY2024 (Dec) by CEO pay:

$6.8M$18.8M

2nd highest of 9in Krystal Biotech and its pay peers, FY2024 (Dec) by total shareholder return:

$43$289

Pay peer group, FY2024 (Dec) proxy

TG Therapeutics
BridgeBio Pharma
Ultragenyx Pharmaceutical
Halozyme Therapeutics
INSMED
Acadia Pharmaceuticals
PTC Therapeutics
Agios Pharmaceuticals
Amicus TherapeuticsNot disclosedNot disclosed
Apellis PharmaceuticalsNot disclosedNot disclosed
Biocryst PharmaceuticalsNot disclosedNot disclosed
Blueprint MedicinesNot disclosedNot disclosed
Corcept TherapeuticsNot disclosedNot disclosed
Harmony Biosciences HoldingsNot disclosedNot disclosed
ImmunityBioNot disclosedNot disclosed
Intra-Cellular TherapiesNot disclosedNot disclosed
Iovance BiotherapeuticsNot disclosedNot disclosed
SpringWorks TherapeuticsNot disclosedNot disclosed
VericelNot disclosedNot disclosed
19 companies

Changes by year

No proxy on file names a change to the peer group.

The comes from the company's proxy. CEO pay and of each company come from its own Pay versus Performance table for the same fiscal year. Each company counts TSR from its own start year, so two values compare only when the start years match.